azacitidine has been researched along with toluene in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Boltze, C; Diab-Assef, M; Foltzer-Jourdainne, C; Gali-Muhtasib, H; Hartig, R; Roessner, A; Rohrbeck, A; Schneider-Stock, R; Schönfeld, P | 1 |
Hou, J; Huang, W; Li, Y; Liu, B; Lv, A; Xing, Y; Yan, X | 1 |
2 other study(ies) available for azacitidine and toluene
Article | Year |
---|---|
5-Aza-cytidine is a potent inhibitor of DNA methyltransferase 3a and induces apoptosis in HCT-116 colon cancer cells via Gadd45- and p53-dependent mechanisms.
Topics: Annexin A5; Apoptosis; Azacitidine; Benzothiazoles; Blotting, Western; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinase Inhibitor p21; DNA (Cytosine-5-)-Methyltransferases; DNA Methyltransferase 3A; DNA, Complementary; DNA, Neoplasm; Down-Regulation; Enzyme Inhibitors; Flow Cytometry; G2 Phase; GADD45 Proteins; Humans; In Situ Nick-End Labeling; Intracellular Signaling Peptides and Proteins; Methylation; Proteins; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Thiazoles; Toluene; Tumor Suppressor Protein p53 | 2005 |
Inhibition of p53-p21 pathway promotes the differentiation of rat bone marrow mesenchymal stem cells into cardiomyocytes.
Topics: Animals; Apoptosis; Azacitidine; Benzothiazoles; Bone Marrow Cells; Cell Proliferation; Cells, Cultured; Cyclin-Dependent Kinase Inhibitor p21; Decitabine; Down-Regulation; Leukocyte Common Antigens; Male; Mesenchymal Stem Cells; Myocytes, Cardiac; Rats; Rats, Sprague-Dawley; Toluene; Tumor Suppressor Protein p53 | 2011 |